• Fri news: Pfizer’s $1B Chinese commitment. RFK Jr. and pharma. Eisai dials back Leqembi forecast. US diabetes burden increase. JNJ gets Varipulse approval. See more on our front page

BioNTech Announces First Patient Dosed in Phase 2 Clinical Trial of mRNA-based BNT111 in...

cafead

Administrator
Staff member
  • cafead   Jun 18, 2021 at 10:42: AM
via First program from BioNTech's fully-owned mRNA cancer vaccine platform FixVac treats patients in a randomized clinical Phase 2 clinical trial

article source